Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients TreatedWith Epidermal Growth Factor Receptor Inhibitors and Capecitabine

Cubiro Xavier; Planas-Ciudad Sergi; Pilar Garcia-Muret Ma; Puig Lluis

首页> 外文期刊>JAMA dermatology >Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients TreatedWith Epidermal Growth Factor Receptor Inhibitors and Capecitabine

【24h】

Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients TreatedWith Epidermal Growth Factor Receptor Inhibitors and Capecitabine

机译：针对Paronychia和Pseudo脓性肉芽肿的局部蒂莫尔治疗表皮生长因子受体抑制剂和Capecitabine治疗的患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《JAMA dermatology》 |2018年第1期|共2页
作者
Cubiro Xavier; Planas-Ciudad Sergi; Pilar Garcia-Muret Ma; Puig Lluis;
展开▼
作者单位

Univ Autonoma Barcelona Dept Dermatol Hosp Santa Creu &

St Pau Barcelona Spain;

Univ Autonoma Barcelona Dept Dermatol Hosp Santa Creu &

St Pau Barcelona Spain;

Univ Autonoma Barcelona Dept Dermatol Hosp Santa Creu &

St Pau Barcelona Spain;

Univ Autonoma Barcelona Dept Dermatol Hosp Santa Creu &

St Pau Barcelona Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients TreatedWith Epidermal Growth Factor Receptor Inhibitors and Capecitabine [J] . Cubiro Xavier, Planas-Ciudad Sergi, Pilar Garcia-Muret Ma, JAMA dermatology . 2018,第1期

机译：针对Paronychia和Pseudo脓性肉芽肿的局部蒂莫尔治疗表皮生长因子受体抑制剂和Capecitabine治疗的患者
2. Topical betaxolol for treating relapsing paronychia with pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors [J] . Yen Chi-Feng, Hsu Chao-Kai, Lu Chun-Wei Journal of the American Academy of Dermatology . 2018,第6期

机译：用于治疗Paronychia与表皮生长因子受体抑制剂诱导的皮肤肉芽肿样病灶复发的局部甲状腺醇
3. Case series showing the efficacy of 5‐aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor‐induced paronychia and pyogenic granuloma‐like lesions [J] . Panariello L., Donnarumma M., Cinelli E., British Journal of Dermatology . 2019,第3期

机译：案例系列显示5-氨基乙酰乙酸光动力治疗表皮生长因子受体抑制剂诱导的Paronychia和化脓性肉芽肿样病变的疗效
4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：非小细胞肺癌患者对一线表皮生长因子受体酪氨酸激酶抑制剂耐药后初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子19缺失与T790M突变频率的关系
7. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors [O] . Huang-Chih Chang, Yu-Mu Chen, Chia-Cheng Tseng, 2017

机译：表皮生长因子受体基因表达水平对表皮生长因子受体肿瘤腺癌患者临床结果的影响，采用一线表皮生长因子受体 - 酪氨酸激酶抑制剂

Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients TreatedWith Epidermal Growth Factor Receptor Inhibitors and Capecitabine

著录项

相似文献

相关主题

期刊订阅